Suppr超能文献

新加坡甲状腺癌发病率上升并非仅由微小乳头状亚型所致。

Rising incidence of thyroid cancer in Singapore not solely due to micropapillary subtype.

作者信息

Shulin J H, Aizhen J, Kuo S M, Tan W B, Ngiam K Y, Parameswaran R

机构信息

Division of Endocrine Surgery, National University Hospital , Singapore.

National Registry of Disease Office, Health Promotion Board , Singapore.

出版信息

Ann R Coll Surg Engl. 2018 Apr;100(4):295-300. doi: 10.1308/rcsann.2018.0004. Epub 2018 Mar 15.

Abstract

Introduction The annual incidence of thyroid cancer is known to vary with geographic area, age and gender. The increasing incidence of thyroid cancer has been attributed to increase in detection of micropapillary subtype, among other factors. The aim of the study was to investigate time trends in the incidence of thyroid cancer in Singapore, an iodine-sufficient area. Materials and methods Data retrieved from the Singapore National Cancer Registry on all thyroid cancers that were diagnosed from 1974 to 2013 were reviewed. We studied the time trends of thyroid cancer based on gender, race, pathology and treatment modalities where available. Results The age-standardised incidence rate of thyroid cancer increased to 5.6/100,000 in 2013 from 2.5/100,000 in 1974. Thyroid cancer appeared to be more common in women, with a higher incidence in Chinese and Malays compared with Indians. Papillary carcinoma is the most common subtype. The percentage of papillary microcarcinoma has remained relatively stable at around 38% of all papillary cancers between 2007 and 2013. Although the incidence of thyroid cancer has increased since 1974, the mortality rate has remained stable. Conclusion This trend of increase in incidence of thyroid cancer in Singapore compares with other published series; however, the rise seen was not solely due to micropapillary type. Thyroid cancer was also more common in Chinese and Malays compared with Indians for reasons that needs to be studied further.

摘要

引言 已知甲状腺癌的年发病率会因地理区域、年龄和性别而有所不同。甲状腺癌发病率的上升归因于微乳头亚型的检出增加等因素。本研究的目的是调查碘充足地区新加坡甲状腺癌发病率的时间趋势。

材料与方法 回顾了从新加坡国家癌症登记处检索到的1974年至2013年期间所有确诊的甲状腺癌数据。我们根据性别、种族、病理和可用的治疗方式研究了甲状腺癌的时间趋势。

结果 甲状腺癌的年龄标准化发病率从1974年的2.5/10万上升至2013年的5.6/10万。甲状腺癌在女性中似乎更为常见,与印度人相比,华人和马来人的发病率更高。乳头状癌是最常见的亚型。2007年至2013年期间,微小乳头状癌在所有乳头状癌中所占的百分比相对稳定,约为38%。尽管自1974年以来甲状腺癌的发病率有所上升,但其死亡率一直保持稳定。

结论 新加坡甲状腺癌发病率上升的这一趋势与其他已发表的系列研究结果相符;然而,发病率的上升并非仅仅由于微乳头型。与印度人相比,甲状腺癌在华人和马来人中也更为常见,其原因有待进一步研究。

相似文献

1
Rising incidence of thyroid cancer in Singapore not solely due to micropapillary subtype.
Ann R Coll Surg Engl. 2018 Apr;100(4):295-300. doi: 10.1308/rcsann.2018.0004. Epub 2018 Mar 15.
4
Micropapillary carcinoma: Description and rise in incidence in the French Marne-Ardennes thyroid cancer registry.
Ann Endocrinol (Paris). 2019 Sep;80(4):229-233. doi: 10.1016/j.ando.2019.06.001. Epub 2019 Jul 8.
5
Incidence of thyroid cancer in the Kingdom of Saudi Arabia, 2000-2010.
Hematol Oncol Stem Cell Ther. 2013 Jun;6(2):58-64. doi: 10.1016/j.hemonc.2013.05.004. Epub 2013 Jun 10.
6
Thyroid cancers in Singapore 1968-'77.
Trop Geogr Med. 1982;34(4):303-8.
7
Thyroid cancer in Luxembourg: a national population-based data report (1983-1999).
BMC Cancer. 2006 Apr 24;6:102. doi: 10.1186/1471-2407-6-102.
10
Papillary thyroid microcarcinoma in Denmark 1996-2008: a national study of epidemiology and clinical significance.
Thyroid. 2013 Sep;23(9):1159-64. doi: 10.1089/thy.2012.0595. Epub 2013 Aug 28.

引用本文的文献

1
The impact of lymph node ratio on disease recurrence in papillary thyroid microcarcinoma.
Ann R Coll Surg Engl. 2023 Sep;105(7):632-638. doi: 10.1308/rcsann.2022.0094.
2
Role of Truncated -GalNAc Glycans in Cancer Progression and Metastasis in Endocrine Cancers.
Cancers (Basel). 2023 Jun 21;15(13):3266. doi: 10.3390/cancers15133266.
3
Hashimoto's thyroiditis on outcomes in papillary thyroid cancer revisited: experience from South East Asia.
Ann R Coll Surg Engl. 2022 Jun;104(6):465-471. doi: 10.1308/rcsann.2021.0224. Epub 2022 Jan 4.
4
Papillary thyroid microcarcinoma with lung metastases: a case report and review of the literature.
Thyroid Res. 2021 Jun 11;14(1):15. doi: 10.1186/s13044-021-00106-0.
5
Factors Associated with Malignancy in Patients with Maximal Thyroid Nodules ≥2 Cm.
Cancer Manag Res. 2021 Jun 4;13:4473-4482. doi: 10.2147/CMAR.S303715. eCollection 2021.

本文引用的文献

2
Papillary thyroid microcarcinoma: time to shift from surgery to active surveillance?
Lancet Diabetes Endocrinol. 2016 Nov;4(11):933-942. doi: 10.1016/S2213-8587(16)30180-2. Epub 2016 Aug 20.
3
Radiation and risk of thyroid cancer: Fukushima and Chernobyl.
Lancet Diabetes Endocrinol. 2016 Aug;4(8):647. doi: 10.1016/S2213-8587(16)30112-7.
5
Parity and thyroid cancer risk: a meta-analysis of epidemiological studies.
Cancer Med. 2016 Apr;5(4):739-52. doi: 10.1002/cam4.604. Epub 2015 Dec 29.
7
Dietary Factors Affecting Thyroid Cancer Risk: A Meta-Analysis.
Nutr Cancer. 2015;67(5):811-7. doi: 10.1080/01635581.2015.1040517. Epub 2015 May 21.
8
Age-Period-Cohort Analysis of Thyroid Cancer Incidence in Korea.
Cancer Res Treat. 2015 Jul;47(3):362-9. doi: 10.4143/crt.2014.110. Epub 2014 Dec 2.
9
Overdiagnosis and screening for thyroid cancer in Korea.
Lancet. 2014 Nov 22;384(9957):1848. doi: 10.1016/S0140-6736(14)62242-X. Epub 2014 Nov 21.
10
[Analysis of incidence and mortality of thyroid cancer in China, 2010].
Zhonghua Yu Fang Yi Xue Za Zhi. 2014 Aug;48(8):663-8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验